Bridgebio Pharma, Inc. · NASDAQ:BBIO

Kumar Neil sold 26,103 Bridgebio Pharma, Inc. shares (Form 4)

Traded May 21, 2026 · Filed May 26, 2026

On May 21, 2026, Kumar Neil (Director, Chief Executive Officer) sold 26,103 Bridgebio Pharma, Inc. shares at an average US$69.44 for US$1.81M under a trading plan, leaving 243,327 shares. Filed May 26, 2026 (Form 4).

Sold: 26,103 shares
Price: US$69.44 average (US$67.57 to US$70.92)
Value: US$1.81M
Holding after: 243,327 shares
Trading plan: Yes (Made under a plan set in advance)
Role: Director, Chief Executive Officer

The filing in full

Date	Security	Transaction	Shares	Price	Holding after	Ownership
May 21, 2026	Common Stock	Sale	2,256	US$67.57	267,174	Direct
May 21, 2026	Common Stock	Sale	6,725	US$68.30	260,449	Direct
May 21, 2026	Common Stock	Sale	5,072	US$69.22	255,377	Direct
May 21, 2026	Common Stock	Sale	11,250	US$70.48	244,127	Direct
May 21, 2026	Common Stock	Sale	800	US$70.92	243,327	Direct

Source

View original at SEC

Related